LEXARIA BIOSCIENCE CORP.: capital expenditure payments
Capital expenditure payments for LEXARIA BIOSCIENCE CORP. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All LEXARIA BIOSCIENCE CORP. financial histories
What this measure means
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
Exact concept: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2014-09-01 to 2025-08-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-09-01 | 2025-08-31 | 24,646 | USD | 2025-11-28 | 10-K · 0001640334-25-002225 |
| 2023-09-01 | 2024-08-31 | 43,014 | USD | 2025-11-28 | 10-K · 0001640334-25-002225 |
| 2022-09-01 | 2023-08-31 | 33,748 | USD | 2024-11-26 | 10-K · 0001640334-24-001787 |
| 2021-09-01 | 2022-08-31 | 49,192 | USD | 2023-11-20 | 10-K · 0001640334-23-002227 |
| 2019-09-01 | 2020-08-31 | 0 | USD | 2020-10-15 | 10-K · 0001640334-20-002561 |
| 2018-09-01 | 2019-08-31 | 646,183 | USD | 2020-10-15 | 10-K · 0001640334-20-002561 |
| 2016-09-01 | 2017-08-31 | 0 | USD | 2017-11-27 | 10-K · 0001062993-17-005078 |
| 2015-09-01 | 2016-08-31 | 3,094 | USD | 2018-11-14 | 10-K · 0001640334-18-002165 |
| 2014-09-01 | 2015-08-31 | 0 | USD | 2016-11-29 | 10-K · 0001062993-16-012493 |
Related financial histories
- LEXARIA BIOSCIENCE CORP.: total assets
- LEXARIA BIOSCIENCE CORP.: total liabilities
- LEXARIA BIOSCIENCE CORP.: stockholders equity
- LEXARIA BIOSCIENCE CORP.: cash and cash equivalents
- LEXARIA BIOSCIENCE CORP.: net income or loss
- LEXARIA BIOSCIENCE CORP.: operating cash flow
- LEXARIA BIOSCIENCE CORP.: revenue
- LEXARIA BIOSCIENCE CORP.: contract revenue excluding tax
- LEXARIA BIOSCIENCE CORP.: financing cash flow
- LEXARIA BIOSCIENCE CORP.: investing cash flow
- LEXARIA BIOSCIENCE CORP.: retained earnings or deficit
- LEXARIA BIOSCIENCE CORP.: diluted weighted-average shares
- LEXARIA BIOSCIENCE CORP.: diluted earnings per share
- LEXARIA BIOSCIENCE CORP.: income tax expense or benefit
- LEXARIA BIOSCIENCE CORP.: net property, plant and equipment
- LEXARIA BIOSCIENCE CORP.: share-based compensation expense
- LEXARIA BIOSCIENCE CORP.: operating income or loss
- LEXARIA BIOSCIENCE CORP.: current assets
- LEXARIA BIOSCIENCE CORP.: interest expense
- LEXARIA BIOSCIENCE CORP.: current liabilities
- LEXARIA BIOSCIENCE CORP.: net finite-lived intangible assets
- LEXARIA BIOSCIENCE CORP.: net current accounts receivable
- LEXARIA BIOSCIENCE CORP.: operating expenses
- LEXARIA BIOSCIENCE CORP.: net inventory
- LEXARIA BIOSCIENCE CORP.: gross profit
- LEXARIA BIOSCIENCE CORP.: cost of revenue
- LEXARIA BIOSCIENCE CORP.: research and development expense
Inspect the source
- Entity
- LEXARIA BIOSCIENCE CORP. / CIK 0001348362
- Captured
- 2026-09-20T07:55:03.045Z
- SEC response SHA-256
c8696dbfbdb8ee1a7522ea5b45a8c2d45cb12720b3d84857c1cda6bba2861389
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001348362.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))